Analytical Overview: Alignment Healthcare Inc (ALHC)’s Ratios Tell a Financial Story

In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Alignment Healthcare Inc’s stock clocked out at $8.59, down -1.26% from its previous closing price of $8.70. In other words, the price has decreased by -$1.26 from its previous closing price. On the day, 0.61 million shares were traded. ALHC stock price reached its highest trading level at $8.86 during the session, while it also had its lowest trading level at $8.54.

Ratios:

To gain a deeper understanding of ALHC’s stock, we examine its different ratios. In the meantime, Its Debt-to-Equity ratio is 1.78 whereas as Long-Term Debt/Eq ratio is at 1.78.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on May 30, 2024, Upgraded its rating to Buy and sets its target price to $11 from $7.75 previously.

On May 30, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $10.

Piper Sandler Upgraded its Neutral to Overweight on May 08, 2024, whereas the target price for the stock was revised from $6 to $8.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 15 ’24 when Maroney Dawn Christine sold 20,000 shares for $8.70 per share. The transaction valued at 174,020 led to the insider holds 1,796,097 shares of the business.

MARGOLIS JEFFREY H sold 1,200 shares of ALHC for $10,596 on Aug 14 ’24. The Director now owns 413,533 shares after completing the transaction at $8.83 per share. On Aug 02 ’24, another insider, JOYCE CHRISTOPHER J, who serves as the Chief Legal and Admin. Officer of the company, sold 1,333 shares for $9.00 each. As a result, the insider received 11,998 and left with 405,579 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 1643267072 and an Enterprise Value of 1500572544. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.74 while its Price-to-Book (P/B) ratio in mrq is 13.28. Its current Enterprise Value per Revenue stands at 0.672 whereas that against EBITDA is -14.353.

Stock Price History:

Over the past 52 weeks, ALHC has reached a high of $10.16, while it has fallen to a 52-week low of $4.46. The 50-Day Moving Average of the stock is 1.07%, while the 200-Day Moving Average is calculated to be 21.72%.

Shares Statistics:

It appears that ALHC traded 960.64K shares on average per day over the past three months and 656790 shares per day over the past ten days. A total of 188.95M shares are outstanding, with a floating share count of 88.95M. Insiders hold about 53.50% of the company’s shares, while institutions hold 41.14% stake in the company. Shares short for ALHC as of 1722384000 were 4516753 with a Short Ratio of 4.70, compared to 1719532800 on 3367428. Therefore, it implies a Short% of Shares Outstanding of 4516753 and a Short% of Float of 3.6900000000000004.

Most Popular